BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 21720638)

  • 1. Methods for investigating G-quadruplex DNA/ligand interactions.
    Murat P; Singh Y; Defrancq E
    Chem Soc Rev; 2011 Nov; 40(11):5293-307. PubMed ID: 21720638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
    Jain AK; Bhattacharya S
    Bioconjug Chem; 2011 Dec; 22(12):2355-68. PubMed ID: 22074555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
    Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
    J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Template-assembled synthetic G-quadruplex (TASQ): a useful system for investigating the interactions of ligands with constrained quadruplex topologies.
    Murat P; Bonnet R; Van der Heyden A; Spinelli N; Labbé P; Monchaud D; Teulade-Fichou MP; Dumy P; Defrancq E
    Chemistry; 2010 May; 16(20):6106-14. PubMed ID: 20397247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilizing G-quadruplex formation to target 8-oxoguanine in telomeric sequences.
    Chitranshi P; Xue L
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6357-61. PubMed ID: 21955942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of small molecule ligands for parallel and anti-parallel DNA G-quadruplex structures.
    Garner TP; Williams HE; Gluszyk KI; Roe S; Oldham NJ; Stevens MF; Moses JE; Searle MS
    Org Biomol Chem; 2009 Oct; 7(20):4194-200. PubMed ID: 19795057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding properties of human telomeric quadruplex multimers: a new route for drug design.
    Cummaro A; Fotticchia I; Franceschin M; Giancola C; Petraccone L
    Biochimie; 2011 Sep; 93(9):1392-400. PubMed ID: 21527309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.
    Fedoroff OY; Salazar M; Han H; Chemeris VV; Kerwin SM; Hurley LH
    Biochemistry; 1998 Sep; 37(36):12367-74. PubMed ID: 9730808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double chain reversal loop and two diagonal loops define the architecture of a unimolecular DNA quadruplex containing a pair of stacked G(syn)-G(syn)-G(anti)-G(anti) tetrads flanked by a G-(T-T) Triad and a T-T-T triple.
    Kuryavyi V; Majumdar A; Shallop A; Chernichenko N; Skripkin E; Jones R; Patel DJ
    J Mol Biol; 2001 Jun; 310(1):181-94. PubMed ID: 11419945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structures of quadruplex nucleic acids and their drug complexes.
    Neidle S
    Curr Opin Struct Biol; 2009 Jun; 19(3):239-50. PubMed ID: 19487118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzofuroquinoline derivatives had remarkable improvement of their selectivity for telomeric G-quadruplex DNA over duplex DNA upon introduction of peptidyl group.
    Long Y; Li Z; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
    Bioconjug Chem; 2012 Sep; 23(9):1821-31. PubMed ID: 22871222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure.
    Rezler EM; Seenisamy J; Bashyam S; Kim MY; White E; Wilson WD; Hurley LH
    J Am Chem Soc; 2005 Jul; 127(26):9439-47. PubMed ID: 15984871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [G-quadruplex DNA: myth or reality?].
    Riou JF; Gomez D; Lemarteleur T; Trentesaux C
    Bull Cancer; 2003 Apr; 90(4):305-13. PubMed ID: 12801813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disubstituted 2-phenyl-benzopyranopyrimidine derivatives as a new type of highly selective ligands for telomeric G-quadruplex DNA.
    Wu WB; Chen SH; Hou JQ; Tan JH; Ou TM; Huang SL; Li D; Gu LQ; Huang ZS
    Org Biomol Chem; 2011 Apr; 9(8):2975-86. PubMed ID: 21373680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective targeting of G-quadruplex using furan-based cyclic homooligopeptides: effect on c-MYC expression.
    Agarwal T; Roy S; Chakraborty TK; Maiti S
    Biochemistry; 2010 Sep; 49(38):8388-97. PubMed ID: 20712380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridyl-substituted corrole isomers: synthesis and their regulation to G-quadruplex structures.
    Ma H; Zhang M; Zhang D; Huang R; Zhao Y; Yang H; Liu Y; Weng X; Zhou Y; Deng M; Xu L; Zhou X
    Chem Asian J; 2010 Jan; 5(1):114-22. PubMed ID: 19937863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quadruplex-coupled kinetics distinguishes ligand binding between G4 DNA motifs.
    Halder K; Chowdhury S
    Biochemistry; 2007 Dec; 46(51):14762-70. PubMed ID: 18052204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disubstituted quinazoline derivatives as a new type of highly selective ligands for telomeric G-quadruplex DNA.
    Li Z; Tan JH; He JH; Long Y; Ou TM; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2012 Jan; 47(1):299-311. PubMed ID: 22104971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA G-Quadruplex in Human Telomeres and Oncogene Promoters: Structures, Functions, and Small Molecule Targeting.
    Chen L; Dickerhoff J; Sakai S; Yang D
    Acc Chem Res; 2022 Sep; 55(18):2628-2646. PubMed ID: 36054116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallographic studies of quadruplex nucleic acids.
    Campbell NH; Parkinson GN
    Methods; 2007 Dec; 43(4):252-63. PubMed ID: 17967696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.